Song Albert S, Poor Taylor A, Abriata Luciano A, Jardetzky Theodore S, Dal Peraro Matteo, Lamb Robert A
Department of Molecular Biosciences, Northwestern University, Evanston, IL 60208-3500;
Institute of Bioengineering, School of Life Sciences, École Polytechnique Fédérale de Lausanne, CH-1050 Lausanne, Switzerland; Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland;
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):E3844-51. doi: 10.1073/pnas.1608349113. Epub 2016 Jun 22.
Parainfluenza virus 5 (PIV5) is an enveloped, single-stranded, negative-sense RNA virus of the Paramyxoviridae family. PIV5 fusion and entry are mediated by the coordinated action of the receptor-binding protein, hemagglutinin-neuraminidase (HN), and the fusion protein (F). Upon triggering by HN, F undergoes an irreversible ATP- and pH-independent conformational change, going down an energy gradient from a metastable prefusion state to a highly stable postfusion state. Previous studies have highlighted key conformational changes in the F-protein refolding pathway, but a detailed understanding of prefusion F-protein metastability remains elusive. Here, using two previously described F-protein mutations (S443D or P22L), we examine the capacity to modulate PIV5 F stability and the mechanisms by which these point mutants act. The S443D mutation destabilizes prefusion F proteins by disrupting a hydrogen bond network at the base of the F-protein globular head. The introduction of a P22L mutation robustly rescues destabilized F proteins through a local hydrophobic interaction between the N-terminal helix and a hydrophobic pocket. Prefusion stabilization conferred by a P22L-homologous mutation is demonstrated in the F protein of Newcastle disease virus, a paramyxovirus of a different genus, suggesting a conserved stabilizing structural element within the paramyxovirus family. Taken together, the available data suggest that movement of the N-terminal helix is a necessary early step for paramyxovirus F-protein refolding and presents a novel target for structure-based drug design.
副流感病毒5型(PIV5)是副粘病毒科的一种包膜单链负义RNA病毒。PIV5的融合和进入由受体结合蛋白血凝素神经氨酸酶(HN)和融合蛋白(F)的协同作用介导。在HN触发后,F经历不可逆的、不依赖ATP和pH的构象变化,从亚稳态的预融合状态沿着能量梯度转变为高度稳定的融合后状态。先前的研究突出了F蛋白重折叠途径中的关键构象变化,但对预融合F蛋白亚稳定性的详细理解仍然难以捉摸。在这里,我们使用两个先前描述的F蛋白突变(S443D或P22L),研究调节PIV5 F稳定性的能力以及这些点突变发挥作用的机制。S443D突变通过破坏F蛋白球状头部底部的氢键网络使预融合F蛋白不稳定。P22L突变的引入通过N端螺旋与疏水口袋之间的局部疏水相互作用有力地挽救了不稳定的F蛋白。在不同属的副粘病毒新城疫病毒的F蛋白中证实了由P22L同源突变赋予的预融合稳定性,这表明副粘病毒科内存在保守的稳定结构元件。综上所述,现有数据表明N端螺旋的移动是副粘病毒F蛋白重折叠的必要早期步骤,并且为基于结构的药物设计提供了一个新的靶点。